London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that ...

Sinusitis is a condition that occurs when sinuses become inflamed due to infections Read this article to know what might be ...

Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...

(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.

CTB-201 is under development for the treatment of chronic sinusitis. It is administered as intranasal spray. It is a preparation of recombinant human CC10 protein (rhCC10). CC10 was the most abundant ...

IntroductionThe demand for ENT (Ears, Nose, and Throat) treatment solutions is rising significantly due to the increasing ...

Experiencing chronic sinusitis, hearing loss, ear infections, sore throats, or colds that lasts more than a week or keeps coming back? Then it’s time to see an otolaryngologist.

If you have chronic sinus infections, you might need additional medications or even surgery to deal with underlying causes. If you have the flu or COVID-19, you might get an antiviral drug to ...